Teleflex Incorporated (LON:0ADI)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 3.58B -44.9% |
| Revenue (ttm) | 1.48B +17.3% |
| Net Income | -672.89M |
| EPS | -15.04 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 16.10 |
| Dividend | 1.02 (0.85%) |
| Ex-Dividend Date | Mar 6, 2026 |
| Volume | 51 |
| Average Volume | 47 |
| Open | 120.33 |
| Previous Close | n/a |
| Day's Range | 120.33 - 120.33 |
| 52-Week Range | 120.32 - 135.90 |
| Beta | n/a |
| RSI | n/a |
| Earnings Date | Feb 26, 2026 |
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and col... [Read more]
News
o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning
DALLAS--(BUSINESS WIRE)--o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global ...
Teleflex: More Clarity And More Questions
Teleflex faces a complex transition after divesting major business units at low multiples, creating uncertainty around future earnings power. Teleflex now trades at 17–18x forward earnings with a stro...
Teleflex Incorporated (TFX) Q4 2025 Earnings Call Transcript
Teleflex Incorporated (TFX) Q4 2025 Earnings Call Transcript
Teleflex Announces Quarterly Dividend
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. Th...
Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the year ended December 31, 2025. Full year 2025 continuing operations financial su...
Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Ti...
Teleflex Announces Leadership Transition
Stuart Randle Appointed Interim President and CEO Board Initiates Search for Permanent CEO Dr. Stephen Klasko Appointed Chairman of the Board Company Provides Update on Preliminary Full Year 2025 Reve...
Teleflex: Selling, But How Much?
Teleflex Incorporated rebounded from lows after announcing a $2.03B divestiture of Acute Care, Interventional Urology, and OEM businesses. TFX will use $1B of net proceeds for share buybacks, reducing...
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
NEW YORK--(BUSINESS WIRE)--Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the...
Teleflex to sell three of its businesses for $2.03 billion
Medical device maker Teleflex said on Tuesday it will sell three of its business units for a total of $2.03 billion in cash.
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
Board of Directors authorizes new $1 billion share repurchase program Board of Directors authorizes new $1 billion share repurchase program
Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Teleflex Incorporated ( TFX) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Liam Kelly - Chairman, President & CEO Conference Call Participants Matthew...
Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript
Teleflex Incorporated ( TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business November 14, 2025 8:00 AM EST Company Participants Lawrence Keusch - Vice ...
Teleflex to Present at the Jefferies Global Healthcare Conference in London
WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 202...
These Analysts Cut Their Forecasts On Teleflex Following Q3 Results
Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday.
Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript
Teleflex Incorporated ( TFX) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy Development Liam Kelly - Chairma...
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 28, 2025.
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m....
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents
Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Teleflex Incorporated (NYSE:TFX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 3:20 PM EDT Company Participants Liam Kelly - Chairman, President & CEO Conference Call Part...
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York...
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment. 1 - 4 Initial cases have now been...
Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript
Teleflex Incorporated (NYSE:TFX) Q2 2025 Earnings Call July 31, 2025 8:00 AM ET Company Participants John R. Deren - Executive VP & CFO Lawrence Soren Keusch - Vice President of Investor Relations & ...
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
WAYNE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 29, 2025.
Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax
The global Chest Drainage Catheters Market, covering product types like thoracic and pleural drainage catheters and applications in cardiothoracic surgery and pneumothorax, is forecast to grow with a ...